Global News Who Should Take Lormalzi? Alzheimer’s Expert Explains Benefits And Risks Source Author May 14, 2026 1 minute readNeurologists say Lormalzi (donanemab), India’s newly launched Alzheimer’s therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.Post navigationPrevious: Children In Bihar Seen Playing With Endangered Gangetic Dolphin, Video Sparks OutrageNext: Can A Simple 2-Finger Pulse Test Reveal Heart Problems? Doctor Explains Related Stories Global News Death Toll In explosion At Firecracker Unit In MP’s Dewas Rises To 5, Factory Owner Held Source Author May 14, 2026 Global News Dilapidated buildings, no toilets for girls: Audit flags safety concerns at Delhi’s CM SHRI school Source Author May 14, 2026 Global News Outer Delhi rape: Bus halted near Nangloi police station for 1.5 hrs before woman got off Source Author May 14, 2026
